As the level of interest in aging research increases, there is a growing number of geroprotectors, or therapeutic interventions that aim to extend the healthy lifespan and repair or reduce aging-related damage in model organisms and, eventually, in humans. There is a clear need for a manually-curated database of geroprotectors to compile and index their effects on aging and age-related diseases and link these effects to relevant studies and multiple biochemical and drug databases. Here, we introduce the first such resource, Geroprotectors (http://geroprotectors.org). Geroprotectors is a public, rapidly explorable database that catalogs over 250 experiments involving over 200 known or candidate geroprotectors that extend lifespan in model organisms. Each compound has a comprehensive profile complete www.impactaging.com 616
INTRODUCTION
Aging is a complex biological process involving the progressive breakdown of cellular homeostatic mechanisms and buildup of molecular damage [1] [2] [3] [4] . Aging opens the door to disease and a gradual decline in function, and as such anti-aging interventions have been sought since the beginning of time. Modern times call for the expedition of this search. Age demographics are shifting to the right and at record rates [5, 6] , suppressing economic growth in developed countries and increasing the risk of economic collapse [7] . With this shift, Alzheimer's disease prevalence will soar in the coming decades [8] , as will that of a number of other chronic, debilitating diseases requiring long term health care [9] .
Geroprotectors are interventions that aim to prevent, slow, or reverse the processes of aging in model organisms or humans such that the lifespan, and particularly the healthy lifespan, can be extended. They can target any one of many pathways and gene networks involved in aging. While most have only been tested in model organisms, literally hundreds of geroprotectors now exist [10] [11] [12] [13] [14] [15] . So many are now under investigation, in fact, that there is a need to catalog and classify these in a centralized repository and to create qualifying criteria for defining geroprotectors. A working model, based on these criteria, would enhance predictive capabilities in screening and ranking potential geroprotective compounds. This, in turn, would facilitate targeted identification and development of new geroprotectors, thus accelerating time to clinic and reducing costs overall [16] .
Currently, there are several functional approaches to identifying changes that occur during aging and patterns common to both aging and disease [17, 18] . One approach is to help identify geroprotectors that minimize the pathological changes at various levels of organismal organization. Other approaches may include testing compounds that may delay or prevent the onset of cancer, CNS pathologies, and other age-related diseases [19] [20] [21] . There is a clear need for a tracking system that would keep the knowledge of potential geroprotectors accessible and up to date and, in doing so, provide the foundation for evaluating possible geroprotective effects in humans.
A system that could track lifespan experiments and the various properties of each individual geroprotector, such as its side effects, toxicity, and results of prior clinical trials, would serve as a good starting platform for scientists planning longevity experiments or attempting to validate theoretical predictions. To address the growing need for a credible online system for tracking drugs that extend lifespan of various organisms, we have created Geroprotectors.org, a manually curated online database that provides instant access to all of the above. An up-to-date, rapidly explorable system that catalogues and summarizes over 200 geroprotective compounds and links them to over 250 studies that support (or refute) their effects in model organisms, Geroprotectors is for the entrant or expert in the field alike. Its interface is sophisticated, streamlined, and modern, minimizing effort for the user. Its data is manually curated by a team of experts in the field and backed with peer-reviewed literature. Whether browsing or seeking in-depth information on a geroprotector of interest, users can do so without investing time in extensive literature searches or learning complicated systems. Geroprotectors is an intuitive, visual, comprehensive collection of anti-aging interventions that will be a valuable biogerontological resource. Presently, it only tracks drugs that have been shown to extend lifespan in model organisms. However, since some of the drugs that are effective against agingassociated pathologies in humans may also act as geroprotectors [22, 23] , these drugs may also be included in the database in the future. These drugs can be submitted using the "submit" form.
RESULTS
The motivation behind the creation of the Geroprotectors database was to provide a one-stop resource for researchers interested in anti-aging compounds, saving countless hours of data mining, literature review, and expert analysis. As a result, a platform for cross-species, cross-study comparison of with biochemistry, mechanisms, and lifespan effects in various model organisms, along with information ranging from chemical structure, side effects, and toxicity to FDA drug status. These are presented in a visually intuitive, efficient framework fit for casual browsing or in-depth research alike. Data are linked to the source studies or databases, providing quick and convenient access to original data. The Geroprotectors database facilitates cross-study, cross-organism, and cross-discipline analysis and saves countless hours of inefficient literature and web searching. Geroprotectors is a onestop, knowledge-sharing, time-saving resource for researchers seeking healthy aging solutions.
www.impactaging.com the effects of these compounds was created. The interface was developed to make it visually appealing and intuitive for rapid, effortless overviews of geroprotective compounds, with links to original studies and other databases for users seeking further detail. The site was not designed as a mere list of geroprotectors and their phenotypic effects; instead, a comprehensive intervention profile was created for each compound, including its biochemistry and bioactivity, its lifeextending effects (and refutations), its toxicity and side effects, and its current drug status. We molded compound profiles around criteria that will be important in developing a working model for geroprotector candidacy. Figure 1 presents a visual overview of the content, data sources, and user-directed exploration of these within Geroprotectors.
Analysis of experiments related to geroprotective compounds
The database contains summaries of more than 250 experiments involving over 200 geroprotective compounds. Each study was manually selected from the existing biomedical literature by searching the PubMed database (http://www.ncbi.nlm.nih.gov/pubmed) using keywords relevant to pharmacological interventions in aging. Effects on lifespan and experimental conditions (e.g. age, gender, nutrient medium, model organism) were then retrieved. Lifespan parameters included average, median, and maximum lifespan and reduced mortality. These were entered into Geroprotectors in table format, facilitating cross-organism and cross-study comparison of results. All entries in Geroprotectors have links to original publications, making access to raw data fast and convenient. For any given compound, links to relevant studies can be accessed directly from search results or within each compound profile under the Lifespan Experiments tab, which contains a convenient at-a-glance summary of experimental conditions and results. Criteria for inclusion of studies were as follows:
Articles contain clear information about model organism, compounds tested, experimental conditions, age at treatment, and results. (2) Experiments were performed on multicellular and/or unicellular organisms. In vitro studies were excluded to avoid the question of whether in vitro replicative and chronological life extension translates to whole organism life extension. (3) Experiments were performed using wild-type strains to avoid model animals with mutations predisposing them to a particular pathology. 
www.impactaging.com
Articles refuting life extending effects of candidate geroprotectors were also included to ensure objectivity and allow users to be informed of and interpret any contradicting findings. These articles are listed and linked under Opposite Effect within each compound's Lifespan Experiments page.
Analysis of compounds with geroprotective activity
In addition to information about lifespan experiments for each compound, we provide biochemical and mechanistic profiles for each entry that are comprehensive yet presented in an at-a-glance style for user convenience. We developed the profiles in accordance with what we wish to promote as criteria important in developing a working model of geroprotectors.
Compound profiles included the following:
(1) Aliases: For a convenient and effective search, we included aliases of substances tested in experiments. This data was obtained from PubChem database (http://www.pubchem.ncbi.nlm.nih.gov).
(2) FDA Drug Status: Several federal drug administration (FDA)-approved compounds with acceptable safety profiles in humans were shown to have geroprotective effects in model organisms. An FDA/Center for Drug Evaluation and Research database (http://www.accessdata.fda.gov/scripts/cder/drugsatfda/i ndex.cfm) search was performed using Drug Name, Active Ingredient, or Application Number to find out whether each compound is FDA-approved. The status of each compound was gained from DrugBank Therapeutic Target Database, which uses the following notation: Microbes may preserve host function through regulation of energy homeostasis and immunity during reproductive life; however, it is also conceivable that selection occurs for organisms that contribute to host demise after reproductive life [24] . Therefore we implemented an additional search both of PubMed and http://www.selleckchem.com/ to find out whether candidates to geroprotectors possess antibacterial, antifungal or antiviral activity.
(8) Age-related pathologies and mechanisms: We also investigated associations between compounds and agerelated pathologies (chronic inflammation, cancer, amyloid aggregation etc.), activation of pro-longevity mechanisms (hormesis, caloric restriction mimetics, stress resistance etc.), and suppression of pro-aging mechanisms (metal ion chelating, antioxidant defense, excessive protein biosynthesis inhibition, cellular senescence). Each of these is an important factor in rating potential geroprotectors. Age-related pathologies were selected based on the availability of data about their connection with compounds in the database.
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Protein databases
UniProt [55] http://www.uniprot.org/ The largest database of the annotated proteins.
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Mechanisms of aging and longevity were selected based on major theories of aging, such as the theory of mutation accumulation, the theory of programmed cell death, etc. [4] .
(9) Biomarkers of aging: Biomarkers of aging are minimally or non-invasive, universal and stable physiological and biochemical indicators which reflect real biological age [25] . They are unique, easily detectable and measurable factors, which can change over an individual's lifespan [26, 27] . Therefore, it is particularly important in screening for compounds which have potential geroprotective effects to understand their influence on the biomarkers of aging. For this reason, we have identified studies that demonstrate the influence of the compounds annotated in our database on aging biomarkers.
(10) Other links: Databases additionally contain links to Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/), transcriptional signature changes from LINCSCLOUD L1000 assay (www.lincscloud.org/), natural sources of substances that are not synthetized, and structural analogs. All databases integrated with Geroprotectors.org are summarized in Table 1 .
Visualization and data structure of database
The Geroprotectors database integrates information submitted in four blocks ( Figure 1 ): (1) Lifespan experiments: abstracts and summarized results of studies demonstrating lifeextending effects of a given compound. (2) Compounds: data about geroprotective compounds.
Clinical trials databases
Clinical Trials [56, 57] www.impactaging.com
Mechanisms: involvement of compound in well-known mechanisms of longevity and aging suppression. (4) Age-related pathologies: actions of compound on the most prevalent and well-studied age-related conditions and associated diseases.
The compounds data is divided into 3 blocks. The first block contains image, name, a short description, and links to other chemical databases. It also includes information about the number of clinical trials and drug status. The second block includes biological, pharmacological, toxicological information and mechanisms of longevity. The third block is dedicated to each compound's associations with age-related pathologies (chronic inflammation, cancer, amyloid aggregation etc.).
Integration with biochemical and drug databases
Compounds and mechanisms were described using multiple chemical and biological databases. Compound profiles include a short description, any aliases, chemical structure, toxicity profile, clinical usage, biological and pharmacological activity, chemical interactions, etc. All substances were integrated with the top chemical databases, including PubChem, ChemSpider, DrugBank, CHEBIL, UniProt, and GenAge (Table 2 ). www.impactaging.com
Comparison with existing aging databases
Several free-access databases already exist in regards to aging research, each of which fills a specific need and takes a unique approach (Table 3) . Some of these databases do contain information about geroprotectors, particularly AgeFactDB by JenAge, which profiles phenotypic effects of 91 compounds associated with aging, along with genes and other interventions related to aging. However, none provides a comprehensive list of current and candidate geroprotectors and complete summary of information on each compound. Also, none contain biochemical and mechanistic profiles of the geroprotective compounds integrated with external [62, 63, 66] , 56% in Nothobranchius furzeri [65] , and 13% in Drosophila melanogaster [64] . At this point, the researcher can do one of two things: 1) go directly to the literature to read more about any one of these seven studies by clicking on the corresponding PubMed links in the last column of the [61] . This and the other six articles are accessed by tabs at the top of this page. To access the C. elegans experiments, the researcher clicks on one of the two C. elegans tabs and the title abstract for one of the three studies appears. Below the abstract, the researcher can see that strain N2 was used. To the right, he sees that the experimental conditions involved agar nematode growth medium + E. coli OP50, and that median life extension for this study was 17.8% [62] . He also sees that 1mM was the concentration of Resveratrol with maximum effect in this study. Scrolling down, there is an additional link to this study followed by a link to a study with opposite effect.
Availability
The Geroprotectors database is available at http://www.geroprotectors.org with the data made available under the permissive Creative Commons licence, allowing data to be used in other analyses. There are options to either download the entire database or to download more focused data using the export tool. Feedback via email is welcome, as are submissions of new data, for which a submission form is provided to ensure that the relevant information is included.
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DISCUSSION
Geroprotectors.org is a unique database publicly available online. Other age-related databases are generally tailored to basic knowledge of longevity/mortality genes, genomes of long-living species (naked mole-rat, bowhead whale, etc.), and aging theories, with relatively little information about antiaging interventions. Geroprotectors.org provides information about life-extending effects of more than 230 geroprotective compounds and summarizes other key data about these compounds in a one-stop, rapidly explorable, clean, sophisticated and intuitive interface. The database is backed by over 250 peer-reviewed studies and chemical/drug databases, which are summarized and linked throughout the site, ensuring literature-supported data, quick and convenient access to original publications, and due credit to the authors of the works. In addition to efforts to ensure accuracy in manual curation, every effort was also made to include studies that refute geroprotective effects to maintain objectivity and ensure a comprehensive look at each compound. As aging continues to rise to the forefront of the list of social and economic problems in the coming decades, resources such as Geroprotectors that enable the multidisciplinary community of biogerontologists and clinicians to come together and share knowledge will become increasingly crucial. In response to this demand, Geroprotectors provides a valuable knowledge-sharing resource for researchers interested in anti-aging solutions.
